Evidence map›Paper›PMID 41387995›Full record

ArticleScientific reports2025

Increased plasma fibronectin mirrors intimal phenotypic switching of vascular smooth muscle cells in moyamoya arteriopathy.

Caroline Asselman, Jozefien Meersschaut, Patrick Willems, Julien Mortier, Frank Vernaillen, Elisabeth Dhondt, Anne Sieben, Sasha Libbrecht, Esperánza Fernandez, Kris Gevaert and 7 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Caroline Asselman *VIB-UGent Center for Medical Biotechnology, VIB, Campus Ardoyen, Technologiepark-Zwijnaarde 75, 9052, Ghent, Belgium.
Jozefien Meersschaut *VIB-UGent Center for Medical Biotechnology, VIB, Campus Ardoyen, Technologiepark-Zwijnaarde 75, 9052, Ghent, Belgium.
Patrick Willems *VIB-UGent Center for Medical Biotechnology, VIB, Campus Ardoyen, Technologiepark-Zwijnaarde 75, 9052, Ghent, Belgium.
Julien MortierVIB-UGent Center for Inflammation Research, 9052, Ghent, Belgium.
Frank VernaillenVIB-UGent Center for Inflammation Research, 9052, Ghent, Belgium.
Elisabeth DhondtDepartment of Vascular and Interventional Radiology, Ghent University Hospital, 9000, Ghent, Belgium.
Anne SiebenDepartment of Pathology, Antwerp University Hospital, 2650, Antwerp, Belgium.
Sasha LibbrechtDepartment of Pathology, Antwerp University Hospital, 2650, Antwerp, Belgium.
Esperánza FernandezVIB-UGent Center for Medical Biotechnology, VIB, Campus Ardoyen, Technologiepark-Zwijnaarde 75, 9052, Ghent, Belgium.
Kris GevaertVIB-UGent Center for Medical Biotechnology, VIB, Campus Ardoyen, Technologiepark-Zwijnaarde 75, 9052, Ghent, Belgium.
Ward De SpiegelaereLaboratory of Morphology, Faculty of Veterinary Medicine, Ghent University, 9820, Merelbeke, Belgium.
Evelien Van HammeVIB-UGent Center for Inflammation Research, 9052, Ghent, Belgium.
Veerle De HerdtDepartment of Neurology, Ghent University Hospital, 9000, Ghent, Belgium.
Jo Van DorpeDepartment of Pathology, Ghent University Hospital, 9000, Ghent, Belgium.
Dimitri HemelsoetDepartment of Neurology, Ghent University Hospital, 9000, Ghent, Belgium.
Bart DermautDepartment of Biomolecular Medicine, Ghent University, 9000, Ghent, Belgium. Bart.Dermaut@ugent.be.
Francis ImpensVIB-UGent Center for Medical Biotechnology, VIB, Campus Ardoyen, Technologiepark-Zwijnaarde 75, 9052, Ghent, Belgium. Francis.Impens@vib-ugent.be.

Funding

European Research Council ERC Consolidator Grant #101089193Fonds Wetenschappelijk Onderzoek 3G0H8318Universiteit Gent 01N10319Universiteit Gent BOF21/GOA/033
6 · The paper itself

Abstract

Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive stenosis of large intracranial arteries and formation of fragile collateral vessels that can be triggered by a broad range of genetic and immune factors. Central to MMD pathology is excessive proliferation of vascular smooth muscle cells (VSMCs) in the intima of affected arteries associated with contractile-to-synthetic phenotypic switching, but the underlying molecular mechanisms remain unclear. To identify dysregulated pathways we studied a cohort of 12 patients with well-documented MMD, including one post-mortem autopsy case, using a multi-omics approach combining whole exome sequencing with plasma proteomics. In addition, we conducted an in-depth spatial proteomics analysis of an occluded artery retrieved post-mortem from one idiopathic patient, combining targeted antibody-based imaging with laser capture microdissection coupled to mass spectrometry. Genetic predispositions for MMD was found in 8 out of 12 patients (67%), including three patients with variants in the major susceptibility gene RNF213 and five with varying underlying genetic conditions (trisomy 21, pathogenic variants in ACTA2, SAMHD1, NFIA). Artery spatial proteomics revealed phenotypic switching of vascular smooth muscle cells associated with infiltration of these cells in the intima, including loss of contractile and gain of synthetic marker proteins. Most notably, increased expression of cellular fibronectin in the occluded lesion was associated with increased levels in patients' plasma, providing a rationale for cellular fibronectin as potential tissue leakage biomarker for moyamoya disease. Finally, infiltration of macrophages and antigen-presenting cells in the intima pointed to a role for inflammatory signals in disease progression. Together, our data provide an unprecedented spatial view on protein changes in an occluded moyamoya artery, revealing intimal infiltration of synthetic vascular smooth muscle cells and antigen-presenting immune cells as key pathological findings, opening novel avenues for future diagnosis and research.

Indexed as

FibronectinsMoyamoya DiseaseMuscle, Smooth, VascularMyocytes, Smooth MuscleTunica IntimaAdenosine TriphosphatasesAdultFemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedPhenotypeProteomicsUbiquitin-Protein LigasesYoung AdultAdenosine TriphosphatasesFibronectinsRNF213 protein, humanUbiquitin-Protein LigasesCerebrovascular disorderFN1Moyamoya diseaseMultiomicsStroke

Identifiers

PMID41387995
PMCPMC12800044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.